Application 074655

Type
ANDA
Sponsor
SANDOZ

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDECAPSULE;ORALEQ 150MG BASENoNo
002RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDECAPSULE;ORALEQ 300MG BASENoYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0615-1354Ranitidine HydrochlorideRanitidine HydrochlorideNCS HealthCare of KY, Inc dba Vangard LabsANDACurrent
0781-2855Ranitidine HydrochlorideRanitidine HydrochlorideSandoz IncANDACurrent
0781-2855Ranitidine HydrochlorideRanitidine HydrochlorideSandoz IncANDACurrent
0781-2855Ranitidine HydrochlorideRanitidine HydrochlorideSandoz IncANDACurrent
0781-2865Ranitidine HydrochlorideRanitidine HydrochlorideSandoz IncANDACurrent
0781-2865Ranitidine HydrochlorideRanitidine HydrochlorideSandoz IncANDACurrent
0781-2865Ranitidine HydrochlorideRanitidine HydrochlorideSandoz IncANDACurrent
21695-337Ranitidine HydrochlorideRanitidine HydrochlorideRebel Distributors CorpANDACurrent
21695-338Ranitidine HydrochlorideRanitidine HydrochlorideRebel Distributors CorpANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
22349ORIG1997-10-22